These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 23024081)

  • 1. Leflunomide in systemic onset Juvenile idiopathic arthritis.
    Jahan A; Dewan V; Yadav TP
    Indian Pediatr; 2012 Sep; 49(9):750-2. PubMed ID: 23024081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A longterm prospective real-life experience with leflunomide in juvenile idiopathic arthritis.
    Alcântara AC; Leite CA; Leite AC; Sidrim JJ; Silva FS; Rocha FA
    J Rheumatol; 2014 Feb; 41(2):338-44. PubMed ID: 24334641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current treatment of juvenile rheumatoid arthritis.
    Ilowite NT
    Pediatrics; 2002 Jan; 109(1):109-15. PubMed ID: 11773549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of synthetic drugs in the biologic era: therapeutic strategies for treating juvenile idiopathic arthritis.
    Hügle B; Horneff G
    Expert Opin Pharmacother; 2016; 17(5):703-14. PubMed ID: 26678914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on the medical treatment of juvenile idiopathic arthritis.
    Hashkes PJ; Laxer RM
    Curr Rheumatol Rep; 2006 Dec; 8(6):450-8. PubMed ID: 17092444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leflunomide, a valid and safe drug for the treatment of chronic anterior uveitis associated with juvenile idiopathic arthritis.
    Molina C; Modesto C; Martín-Begué N; Arnal C
    Clin Rheumatol; 2013 Nov; 32(11):1673-5. PubMed ID: 23828309
    [No Abstract]   [Full Text] [Related]  

  • 7. Leflunomide or methotrexate for juvenile rheumatoid arthritis.
    Silverman E; Mouy R; Spiegel L; Jung LK; Saurenmann RK; Lahdenne P; Horneff G; Calvo I; Szer IS; Simpson K; Stewart JA; Strand V;
    N Engl J Med; 2005 Apr; 352(16):1655-66. PubMed ID: 15843668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the benefits of sequential addition of leflunomide in patients with polyarticular course juvenile idiopathic arthritis failing standard dose methotrexate.
    Chickermane PR; Khubchandani RP
    Clin Exp Rheumatol; 2015; 33(2):287-92. PubMed ID: 25738527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leflunomide is associated with a higher flare rate compared to methotrexate in the treatment of chronic uveitis in juvenile idiopathic arthritis.
    Bichler J; Benseler SM; Krumrey-Langkammerer M; Haas JP; Hügle B
    Scand J Rheumatol; 2015; 44(4):280-3. PubMed ID: 25993023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On beyond methotrexate treatment of severe juvenile rheumatoid arthritis.
    Wallace CA
    Clin Exp Rheumatol; 1999; 17(4):499-504. PubMed ID: 10464566
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of patients with juvenile rheumatoid arthritis with combination of leflunomide and methotrexate].
    Gao JS; Wu H; Tian J
    Zhonghua Er Ke Za Zhi; 2003 Jun; 41(6):435-8. PubMed ID: 14748999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of methotrexate response in Turkish children with oligoarticular and polyarticular juvenile idiopathic arthritis.
    Batu ED; Sönmez HE; Gülhan B; Arıcı ZS; Topaloğlu R; Bilginer Y
    Turk J Pediatr; 2017; 59(1):6-12. PubMed ID: 29168357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Juvenile Idiopathic Arthritis.
    Barut K; Adrovic A; Şahin S; Kasapçopur Ö
    Balkan Med J; 2017 Apr; 34(2):90-101. PubMed ID: 28418334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocorticoids in juvenile idiopathic arthritis.
    Malattia C; Martini A
    Ann N Y Acad Sci; 2014 May; 1318():65-70. PubMed ID: 24738483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term open-label preliminary study of the safety and efficacy of leflunomide in patients with polyarticular-course juvenile rheumatoid arthritis.
    Silverman E; Spiegel L; Hawkins D; Petty R; Goldsmith D; Schanberg L; Duffy C; Howard P; Strand V
    Arthritis Rheum; 2005 Feb; 52(2):554-62. PubMed ID: 15693001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biologicals in Juvenile Idiopathic Arthritis.
    Saini I; Dawman L; Gupta N; Kabra SK
    Indian Pediatr; 2016 Mar; 53(3):260-1. PubMed ID: 27029697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of methotrexate on the temporomandibular joint and facial morphology in juvenile rheumatoid arthritis patients.
    Ince DO; Ince A; Moore TL
    Am J Orthod Dentofacial Orthop; 2000 Jul; 118(1):75-83. PubMed ID: 10893476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bayesian comparative effectiveness study of four consensus treatment plans for initial management of systemic juvenile idiopathic arthritis: FiRst-Line Options for Systemic juvenile idiopathic arthritis Treatment (FROST).
    Nigrovic PA; Beukelman T; Tomlinson G; Feldman BM; Schanberg LE; Kimura Y;
    Clin Trials; 2018 Jun; 15(3):268-277. PubMed ID: 29542334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thalidomide for systemic onset juvenile idiopathic arthritis.
    Sathe K; Khubchandani RP
    Indian Pediatr; 2013 Feb; 50(2):237-9. PubMed ID: 23474929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New drugs and treatment strategies for rheumatoid arthritis].
    Fantini F
    Recenti Prog Med; 2003 Sep; 94(9):361-79. PubMed ID: 12942798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.